Acadia Pharmaceuticals Cash Flow Statement (2010-2025) | ACAD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-66.45M	-43.87M	-14.46M	-43.09M	-113.08M	-34.00M	-27.21M	-41.73M	-42.98M	1.11M	-65.18M	45.75M	16.55M	33.40M	32.77M	143.76M	19.00M	26.66M	71.78M	273.57M
Depreciation and Depletion (Quarter)	0.53M	0.56M	0.62M	0.50M	0.52M	0.52M	0.51M	0.49M	0.43M	0.40M	0.36M	0.31M	0.24M	0.23M	0.23M	0.21M	0.23M	0.21M	0.23M	0.20M
Share-based Compensation (Quarter)	13.18M	22.00M	15.55M	12.88M	14.96M	20.51M	18.31M	14.41M	14.71M	15.15M	18.54M	18.02M	14.75M	15.69M	26.16M	10.45M	11.38M	14.34M	13.18M	13.23M
Gains from Investment Securities (Quarter)				15.09M				16.34M	1.34M	0.98M	0.85M	16.63M	0.41M	12.35M	1.81M	17.52M	1.15M	10.95M	12.51M	4.83M
Non-cash Items (Quarter)				16.42M				1.05M				90.96M				7.00M				79.28M
Cash from Operations (Quarter)	-60.15M	-25.33M	-17.06M	-23.12M	-76.33M	-13.12M	-0.73M	-23.85M	-17.93M	8.20M	-58.95M	85.39M	29.08M	25.01M	63.25M	40.38M	20.32M	63.96M	74.29M	-48.73M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.37M	0.40M	0.40M	-0.64M	-0.45M	-0.10M	0.55M		2.27M	1.40M	1.40M	1.36M	5.29M	2.30M	2.30M	8.48M	2.12M	2.70M	2.70M	-2.74M
Depreciation & Amortization (CF) (Quarter)	0.53M	0.56M	0.62M	0.50M	0.52M	0.52M	0.51M	0.49M	0.43M	0.40M	0.36M	0.31M	0.24M	0.23M	0.23M	0.21M	0.23M	0.21M	0.23M	0.20M
Change in Working Capital
Change in Receivables (Quarter)	-1.48M	4.60M	-4.18M	0.01M	-1.65M	5.24M	-4.16M	0.48M	3.72M	-2.30M	-0.57M	2.35M	1.29M	1.32M	5.46M	-6.20M	7.00M	-0.78M	11.40M	5.09M
Change in Inventory (Quarter)	0.49M	0.39M	3.55M	-0.22M	-0.83M	-0.63M	-0.64M	-0.31M	-0.48M	3.00M	11.22M	15.07M	16.65M	27.15M	1.33M	4.42M	10.45M	4.10M	-1.25M	4.89M
Change in Account Payables (Quarter)	0.36M	0.22M	-1.34M	-0.85M	3.89M	1.09M	-1.85M	2.74M	4.68M	1.39M	-6.50M	5.23M	1.79M	0.55M	-0.80M	-2.89M	1.90M	2.00M	1.65M	-10.84M
Change in Accured Expenses (Quarter)	-1.57M	-9.76M	10.97M	2.21M	-2.66M	1.17M	19.26M	-15.73M	-3.77M	3.95M	54.85M	38.13M	-3.87M	1.09M	2.96M	2.73M	-0.12M	21.47M	27.78M	-48.05M
Other Working Capital Changes (Quarter)	-0.01M	0.00M	-1.06M	-0.73M	-2.12M	-1.85M	3.07M	-1.59M	2.23M	0.26M	-7.51M	22.71M		6.96M	-7.08M	16.71M	0.37M	-3.30M	-0.66M	7.44M
Investing Activities
Capital Expenditures (Quarter)	1.08M	0.04M		0.00M											0.07M	0.45M			0.39M	4.00M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)																	98.84M
Change in Acquisitions & Divestments (Quarter)	159.82M	57.50M	95.00M	110.50M	131.34M	69.58M	159.69M	75.80M	259.41M	7.50M	59.11M	103.76M	66.11M	81.50M	69.10M	111.85M	130.80M	131.39M	125.59M	105.75M
Cash from Investing Activities (Quarter)	30.88M	-17.21M	-156.32M	71.55M	131.34M	-55.80M	15.44M	-17.75M	192.52M	-194.28M	34.11M	-0.35M	-14.04M	-56.19M	-82.46M	122.15M	-124.05M	-43.29M	-79.35M	-55.87M
Financing Activities
Cash from Financing Activities (Quarter)	7.73M	5.00M	1.07M	4.37M	2.47M	3.83M	0.29M	1.61M	1.47M	5.48M	12.75M	5.43M	1.04M	3.56M	0.27M	1.97M	1.84M	15.96M	9.42M	22.67M
Additional items
Exchange Rate Effect (Quarter)	0.01M	-0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	-0.01M	-0.00M		-0.00M	-0.01M	0.01M	0.00M	-0.04M	-0.06M	-0.01M	0.02M		0.01M
Change in Cash (Quarter)	-21.54M	-37.53M	-172.32M	52.80M	57.48M	-65.09M	15.01M	-40.00M	176.05M	-180.60M	-12.10M	90.46M	16.09M	-27.61M	-18.98M	164.44M	-101.89M	36.64M	4.36M	-81.93M
Free Cash Flow (Quarter)	-61.23M	-25.37M	-17.06M	-23.12M	-76.33M	-13.12M	-0.73M	-23.85M	-17.93M	8.20M	-58.95M	85.39M	29.08M	25.01M	63.18M	39.93M	20.32M	63.96M	73.90M	-52.74M
Net Cash Flow (Quarter)	-21.55M	-37.53M	-172.32M	52.79M	57.48M	-65.09M	15.00M	-39.99M	176.05M	-180.60M	-12.09M	90.48M	16.08M	-27.61M	-18.94M	164.50M	-101.89M	36.62M	4.36M	-81.93M

Research Tools

Acadia Pharmaceuticals Cash Flow Statement (2010-2025) | ACAD

Create an account

Sign In

Reset Password